Maria C Rodriguez-Barradas Selected Research

Maria C Rodriguez-Barradas Research Topics

Disease

17	HIV Infections (HIV Infection) 01/2021 - 12/2005
13	Infections 01/2022 - 02/2011
9	Neoplasms (Cancer) 01/2022 - 10/2009
7	Inflammation (Inflammations) 01/2021 - 04/2012
6	Pneumonia (Pneumonitis) 01/2023 - 04/2008
6	COVID-19 12/2022 - 01/2021
6	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 10/2009
5	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 01/2015
5	Hepatitis C 01/2023 - 03/2009
5	Respiratory Tract Infections (Respiratory Tract Infection) 01/2023 - 01/2018
5	Substance-Related Disorders (Drug Abuse) 10/2022 - 10/2014
5	Chronic Obstructive Pulmonary Disease (COPD) 09/2021 - 12/2005
5	Fibrosis (Cirrhosis) 01/2020 - 12/2011
4	Alcoholism (Alcohol Abuse) 01/2023 - 12/2011
4	Viremia 11/2021 - 01/2016
4	Coinfection 01/2021 - 03/2009
3	Human Influenza (Influenza) 01/2022 - 01/2019
3	Myocardial Infarction 01/2020 - 02/2015
3	Bacterial Pneumonia 01/2017 - 12/2005
2	Herpes Zoster 08/2021 - 12/2018
2	Liver Diseases (Liver Disease) 11/2019 - 07/2013
2	Chronic Hepatitis C 11/2018 - 10/2017
2	Ischemic Stroke 01/2018 - 05/2015
2	Virus Diseases (Viral Diseases) 10/2017 - 12/2011
2	Obesity 01/2017 - 10/2014
2	Weight Gain 10/2016 - 06/2015
2	Chronic Disease (Chronic Diseases) 04/2015 - 04/2012
2	Pneumococcal Infections 03/2011 - 10/2008
1	Acute Coronary Syndrome 05/2024
1	Abdominal Pain (Pain, Abdominal) 01/2023
1	Rheumatoid Arthritis 01/2023
1	Frailty 01/2023
1	Vitamin D Deficiency 01/2022
1	Coronavirus Infections 12/2021
1	Cryptococcosis 08/2021
1	Nontuberculous Mycobacterium Infections 08/2021
1	Opportunistic Infections (Opportunistic Infection) 08/2021
1	Progressive Multifocal Leukoencephalopathy 08/2021
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 08/2021
1	Histoplasmosis 08/2021
1	Coccidioidomycosis 08/2021
1	Toxoplasmosis 08/2021
1	Bacteremia 08/2021
1	Tuberculosis (Tuberculoses) 08/2021
1	Esophagitis 08/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021

Drug/Important Bio-Agent (IBA)

13	RNA (Ribonucleic Acid)IBA 01/2020 - 02/2011
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2012
8	Hemoglobins (Hemoglobin)IBA 06/2015 - 04/2008
5	VaccinesIBA 01/2022 - 01/2014
5	insulin receptor-related receptor (IRR)IBA 08/2021 - 07/2014
5	fibrin fragment D (D-dimer)IBA 10/2019 - 04/2012
5	Interleukin-6 (Interleukin 6)IBA 10/2019 - 04/2012
5	LipidsIBA 10/2014 - 11/2004
4	Opioid Analgesics (Opioids)IBA 01/2023 - 01/2019
4	Lipopolysaccharide ReceptorsIBA 01/2017 - 04/2012
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 11/2004
3	N-acetoacetyl-N-deacetylcolchicineIBA 01/2018 - 02/2015
3	Proteins (Proteins, Gene)FDA Link 01/2014 - 10/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 10/2014
2	mRNA VaccinesIBA 01/2022 - 09/2021
2	Transaminases (Aminotransferases)IBA 10/2017 - 10/2017
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2015 - 12/2011
2	CholesterolIBA 01/2014 - 03/2009
2	HDL CholesterolIBA 01/2014 - 08/2002
2	Protease Inhibitors (Protease Inhibitor)IBA 05/2013 - 03/2008
2	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 03/2011 - 10/2008
2	NucleosidesIBA 06/2009 - 03/2008
2	Reverse Transcriptase InhibitorsIBA 06/2009 - 03/2008
1	GlucocorticoidsIBA 01/2023
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2023
1	ProcalcitoninIBA 01/2023
1	Nucleic AcidsIBA 01/2023
1	cyclo(Arg-Pro) (CI 4)IBA 01/2023
1	25-hydroxyvitamin DIBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	AntibodiesIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Messenger RNA (mRNA)IBA 12/2021
1	Immunoglobulin G (IgG)IBA 12/2021
1	COVID-19 VaccinesIBA 12/2021
1	AerosolsIBA 12/2021
1	Bronchodilator Agents (Bronchodilators)IBA 09/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2021
1	Muscarinic AntagonistsIBA 09/2021

Therapy/Procedure

21	Therapeutics 12/2022 - 11/2004
10	Highly Active Antiretroviral Therapy (HAART) 12/2018 - 05/2002
7	Art Therapy 01/2022 - 04/2015
4	Artificial Respiration (Mechanical Ventilation) 01/2021 - 06/2013
3	Polypharmacy 01/2023 - 11/2019
3	N95 Respirators 01/2022 - 01/2019
2	Secondary Prevention 05/2024 - 01/2020
2	Ambulatory Care (Outpatient Care) 03/2020 - 12/2016
1	Percutaneous Coronary Intervention 05/2024
1	Immunotherapy 01/2022
1	Personal Protective Equipment 12/2021
1	Nebulizers and Vaporizers (Inhaler) 09/2021
1	Drug Therapy (Chemotherapy) 08/2021
1	Length of Stay 01/2021